...

Pieris Pharmaceuticals GmbH

Vieraile verkkosivulla

Tietoja työnantajasta

Pieris Pharmaceuticals, Inc. is a, clinical-stage biotechnology company applying its proprietary Anticalin® technology to create differentiated drugs that can help patients suffering from cancer, severe asthma, anemia and other medical conditions with a high unmet medical need.

Anticalins are recombinantly engineered versions of lipocalins, human proteins that naturally bind, store and transport a wide spectrum of molecules. Our libraries of more than 100 billion different Anticalins can virtually bind to any target of interest.

Pieris has a diverse pipeline of Anticalin Therapeutics for a number of different indications and has active, multi-program R&D collaborations with Roche, Daiichi Sankyo, the Sanofi Group, Zydus Cadila and Stelis Biopharma.

Pieris, founded in 2001, was funded by premier biotechnology-focused venture capital firms including OrbiMed Advisors as its lead investor as well as Forbion Capital, Gilde Healthcare Partners, Novo Nordisk Ventures, Global Life Science Ventures, BayTech Venture Capital, Bio-M, TCB, KfW and BayernKapital.

Pieris has become a publicly traded company on December 18, 2014 (NASDAQ:PIRS).

Työnantajan sijainti

Löydä samanlaisia työnantajia

...
KTH Royal Institute of Technology Tukholma, Ruotsi 115 avointa työpaikkaa
...
University of Luxembourg Luxemburg 104 avointa työpaikkaa
...
KU Leuven Leuven, Belgia 91 avointa työpaikkaa
...
Ghent University Gent, Belgia 68 avointa työpaikkaa
...
ETH Zürich Zürich, Sveitsi 62 avointa työpaikkaa
Lisää työnantajia

Kiinnostavia artikkeleita

...
5 Reasons to Pursue Your PhD at EMBL European Molecular Biology Laboratory (EMBL) 4 min arvioitu lukuaika
...
The genetic detectives discovering who we really are University of Turku 5 min arvioitu lukuaika
...
Deciphering the Gut’s Clues to Our Health University of Turku 5 min arvioitu lukuaika
...
Understanding Users to Optimise 3D Experiences Centrum Wiskunde & Informatica (CWI) 5 min arvioitu lukuaika
...
Harnessing the Rhizosphere to Protect Our Soil Free University of Bozen - Bolzano 5 min arvioitu lukuaika
Lisää artikkeleita